SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '924'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_D_MIXD3539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	7 / 12	LEU A 598 GLY A 599 GLY A 601 VAL A 606 LYS A 938 ASN A 941 ASP A 954	924 A1101 ( 4.1A) None None 924 A1101 ( 4.8A) None None 924 A1101 (-3.7A)	1.06A	2fumD-4g34A: 23.4	2fumD-4g34A: 27.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HYY_A_STIA600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	4 / 6	LEU A 598 LYS A 621 VAL A 651 ILE A 885	924 A1101 ( 4.1A) None 924 A1101 (-4.6A) 924 A1101 ( 4.6A)	0.42A	2hyyA-4g34A: 20.6	2hyyA-4g34A: 27.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HYY_B_STIB600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	4 / 6	LEU A 598 LYS A 621 VAL A 651 ILE A 885	924 A1101 ( 4.1A) None 924 A1101 (-4.6A) 924 A1101 ( 4.6A)	0.54A	2hyyB-4g34A: 20.6	2hyyB-4g34A: 27.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PGR_A_DCFA501_2 (ADENOSINE DEAMINASE)	2o7q	BIFUNCTIONAL 3-DEHYDROQUINATE DEHYDRATASE/SHIKIMAT E DEHYDROGENASE (Arabidopsis thaliana)	3 / 3	LEU A 289 LEU A 148 PHE A 291	None None DHK A9241 (-3.4A)	0.61A	2pgrA-2o7qA: 3.7	2pgrA-2o7qA: 23.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CS9_A_NILA600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 10	LEU A 598 VAL A 606 LYS A 621 VAL A 651 ILE A 885 VAL A 952	924 A1101 ( 4.1A) 924 A1101 ( 4.8A) None 924 A1101 (-4.6A) 924 A1101 ( 4.6A) None	0.76A	3cs9A-4g34A: 21.0	3cs9A-4g34A: 27.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CS9_B_NILB600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 9	LEU A 598 VAL A 606 LYS A 621 VAL A 651 ILE A 885 VAL A 952	924 A1101 ( 4.1A) 924 A1101 ( 4.8A) None 924 A1101 (-4.6A) 924 A1101 ( 4.6A) None	0.77A	3cs9B-4g34A: 21.4	3cs9B-4g34A: 27.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CS9_C_NILC600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 9	LEU A 598 VAL A 606 LYS A 621 VAL A 651 ILE A 885 VAL A 952	924 A1101 ( 4.1A) 924 A1101 ( 4.8A) None 924 A1101 (-4.6A) 924 A1101 ( 4.6A) None	0.75A	3cs9C-4g34A: 20.9	3cs9C-4g34A: 27.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G2O_A_SAMA500_1 (PCZA361.24)	2wan	PULLULANASE (Bacillus acidopullulyticu s)	3 / 3	ARG A 756 GLU A 761 ASP A 815	None GOL A1924 (-3.8A) None	0.93A	3g2oA-2wanA: undetectable	3g2oA-2wanA: 16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3K5V_A_STIA2_2 (TYROSINE-PROTEIN KINASE ABL1)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	4 / 6	LEU A 598 LYS A 621 VAL A 651 ILE A 885	924 A1101 ( 4.1A) None 924 A1101 (-4.6A) 924 A1101 ( 4.6A)	0.50A	3k5vA-4g34A: 16.5	3k5vA-4g34A: 26.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3K5V_B_STIB2_2 (TYROSINE-PROTEIN KINASE ABL1)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	4 / 6	LEU A 598 LYS A 621 VAL A 651 ILE A 885	924 A1101 ( 4.1A) None 924 A1101 (-4.6A) 924 A1101 ( 4.6A)	0.48A	3k5vB-4g34A: 18.8	3k5vB-4g34A: 26.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LXK_A_MI1A1125_1 (TYROSINE-PROTEIN KINASE JAK3)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	7 / 12	LEU A 598 GLY A 599 VAL A 606 ALA A 619 LYS A 621 VAL A 651 ASP A 954	924 A1101 ( 4.1A) None 924 A1101 ( 4.8A) 924 A1101 (-3.5A) None 924 A1101 (-4.6A) 924 A1101 (-3.7A)	0.67A	3lxkA-4g34A: 22.3	3lxkA-4g34A: 25.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MSS_D_STID1_2 (TYROSINE-PROTEIN KINASE ABL1)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	4 / 6	VAL A 606 LYS A 621 VAL A 651 ILE A 885	924 A1101 ( 4.8A) None 924 A1101 (-4.6A) 924 A1101 ( 4.6A)	0.39A	3mssD-4g34A: 20.3	3mssD-4g34A: 26.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OG7_A_032A1_1 (AKAP9-BRAF FUSION PROTEIN)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 ALA A 619 CYH A 890 PHE A 943 PHE A 955 GLY A 956	924 A1101 ( 4.8A) 924 A1101 (-3.5A) 924 A1101 (-3.9A) 924 A1101 ( 4.2A) 924 A1101 ( 4.4A) None	0.84A	3og7A-4g34A: 23.6	3og7A-4g34A: 27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OG7_A_032A1_1 (AKAP9-BRAF FUSION PROTEIN)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 ALA A 619 LYS A 621 CYH A 890 PHE A 955 GLY A 956	924 A1101 ( 4.8A) 924 A1101 (-3.5A) None 924 A1101 (-3.9A) 924 A1101 ( 4.4A) None	0.79A	3og7A-4g34A: 23.6	3og7A-4g34A: 27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OG7_A_032A1_1 (AKAP9-BRAF FUSION PROTEIN)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 LYS A 621 LEU A 642 CYH A 890 PHE A 955 GLY A 956	924 A1101 ( 4.8A) None 924 A1101 (-3.9A) 924 A1101 (-3.9A) 924 A1101 ( 4.4A) None	0.75A	3og7A-4g34A: 23.6	3og7A-4g34A: 27.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DM8_B_REAB1501_1 (RETINOIC ACID RECEPTOR BETA)	2wan	PULLULANASE (Bacillus acidopullulyticu s)	5 / 12	LEU A 762 ALA A 763 LEU A 740 PHE A 817 GLY A 778	GOL A1924 (-4.3A) None None None None	1.04A	4dm8B-2wanA: undetectable	4dm8B-2wanA: 13.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IK6_B_LURB201_1 (TRANSTHYRETIN)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	4 / 8	MET A 887 LEU A 883 ALA A 656 LEU A 658	924 A1101 (-3.7A) None None None	0.82A	4ik6B-4g34A: undetectable	4ik6B-4g34A: 18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0W_A_ADNA501_1 (AURORA KINASE A)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	4 / 6	LEU A 598 GLY A 599 VAL A 606 ALA A 619	924 A1101 ( 4.1A) None 924 A1101 ( 4.8A) 924 A1101 (-3.5A)	0.26A	4o0wA-4g34A: 24.3	4o0wA-4g34A: 26.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RKU_A_PQNA5001_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1 PHOTOSYSTEM I REACTION CENTER SUBUNIT IX)	2o7q	BIFUNCTIONAL 3-DEHYDROQUINATE DEHYDRATASE/SHIKIMAT E DEHYDROGENASE (Arabidopsis thaliana)	4 / 8	PHE A 291 SER A 300 ALA A 243 LEU A 269	DHK A9241 (-3.4A) DHK A9241 (-2.8A) DHK A9241 ( 4.6A) DHK A9241 (-3.7A)	0.96A	4rkuA-2o7qA: undetectable 4rkuJ-2o7qA: undetectable	4rkuA-2o7qA: 20.52 4rkuJ-2o7qA: 7.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZV_B_032B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 ALA A 619 CYH A 890 PHE A 943 GLY A 953 PHE A 955	924 A1101 ( 4.8A) 924 A1101 (-3.5A) 924 A1101 (-3.9A) 924 A1101 ( 4.2A) 924 A1101 (-4.6A) 924 A1101 ( 4.4A)	0.99A	4rzvB-4g34A: 23.3	4rzvB-4g34A: 28.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZV_B_032B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 ALA A 619 CYH A 890 PHE A 943 PHE A 955 GLY A 956	924 A1101 ( 4.8A) 924 A1101 (-3.5A) 924 A1101 (-3.9A) 924 A1101 ( 4.2A) 924 A1101 ( 4.4A) None	0.80A	4rzvB-4g34A: 23.3	4rzvB-4g34A: 28.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZV_B_032B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 ALA A 619 LYS A 621 CYH A 890 PHE A 955 GLY A 956	924 A1101 ( 4.8A) 924 A1101 (-3.5A) None 924 A1101 (-3.9A) 924 A1101 ( 4.4A) None	0.73A	4rzvB-4g34A: 23.3	4rzvB-4g34A: 28.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TYJ_A_0LIA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	4 / 6	LEU A 598 VAL A 606 LYS A 621 ILE A 650	924 A1101 ( 4.1A) 924 A1101 ( 4.8A) None None	0.49A	4tyjA-4g34A: 21.6	4tyjA-4g34A: 24.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XK8_A_PQNA844_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1)	2o7q	BIFUNCTIONAL 3-DEHYDROQUINATE DEHYDRATASE/SHIKIMAT E DEHYDROGENASE (Arabidopsis thaliana)	4 / 7	PHE A 291 SER A 300 ALA A 243 LEU A 269	DHK A9241 (-3.4A) DHK A9241 (-2.8A) DHK A9241 ( 4.6A) DHK A9241 (-3.7A)	1.02A	4xk8A-2o7qA: undetectable	4xk8A-2o7qA: 20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 ALA A 619 CYH A 890 PHE A 943 GLY A 953 PHE A 955	924 A1101 ( 4.8A) 924 A1101 (-3.5A) 924 A1101 (-3.9A) 924 A1101 ( 4.2A) 924 A1101 (-4.6A) 924 A1101 ( 4.4A)	0.78A	4xv2A-4g34A: 23.6	4xv2A-4g34A: 27.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 ALA A 619 LYS A 621 CYH A 890 GLY A 953 PHE A 955	924 A1101 ( 4.8A) 924 A1101 (-3.5A) None 924 A1101 (-3.9A) 924 A1101 (-4.6A) 924 A1101 ( 4.4A)	0.92A	4xv2A-4g34A: 23.6	4xv2A-4g34A: 27.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 CYH A 890 PHE A 943 GLY A 953 ASP A 954 PHE A 955	924 A1101 ( 4.8A) 924 A1101 (-3.9A) 924 A1101 ( 4.2A) 924 A1101 (-4.6A) 924 A1101 (-3.7A) 924 A1101 ( 4.4A)	1.43A	4xv2A-4g34A: 23.6	4xv2A-4g34A: 27.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 ALA A 619 CYH A 890 PHE A 943 GLY A 953 PHE A 955	924 A1101 ( 4.8A) 924 A1101 (-3.5A) 924 A1101 (-3.9A) 924 A1101 ( 4.2A) 924 A1101 (-4.6A) 924 A1101 ( 4.4A)	0.77A	5cswA-4g34A: 23.3	5cswA-4g34A: 28.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	5 / 12	VAL A 606 ALA A 619 LYS A 621 CYH A 890 PHE A 955	924 A1101 ( 4.8A) 924 A1101 (-3.5A) None 924 A1101 (-3.9A) 924 A1101 ( 4.4A)	0.73A	5cswA-4g34A: 23.3	5cswA-4g34A: 28.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 ALA A 619 CYH A 890 PHE A 943 GLY A 953 PHE A 955	924 A1101 ( 4.8A) 924 A1101 (-3.5A) 924 A1101 (-3.9A) 924 A1101 ( 4.2A) 924 A1101 (-4.6A) 924 A1101 ( 4.4A)	0.74A	5cswB-4g34A: 23.3	5cswB-4g34A: 28.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 ALA A 619 LYS A 621 CYH A 890 GLY A 953 PHE A 955	924 A1101 ( 4.8A) 924 A1101 (-3.5A) None 924 A1101 (-3.9A) 924 A1101 (-4.6A) 924 A1101 ( 4.4A)	0.92A	5cswB-4g34A: 23.3	5cswB-4g34A: 28.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	5 / 12	VAL A 606 LEU A 642 CYH A 890 PHE A 943 PHE A 955	924 A1101 ( 4.8A) 924 A1101 (-3.9A) 924 A1101 (-3.9A) 924 A1101 ( 4.2A) 924 A1101 ( 4.4A)	0.88A	5cswB-4g34A: 23.3	5cswB-4g34A: 28.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HES_B_032B401_1 (MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	VAL A 606 ALA A 619 LYS A 621 ILE A 885 PHE A 955 GLY A 956	924 A1101 ( 4.8A) 924 A1101 (-3.5A) None 924 A1101 ( 4.6A) 924 A1101 ( 4.4A) None	0.81A	5hesB-4g34A: 22.6	5hesB-4g34A: 27.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	5 / 12	VAL A 606 ALA A 619 ILE A 885 PHE A 943 GLY A 953	924 A1101 ( 4.8A) 924 A1101 (-3.5A) 924 A1101 ( 4.6A) 924 A1101 ( 4.2A) 924 A1101 (-4.6A)	0.49A	5hieA-4g34A: 3.8	5hieA-4g34A: 28.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	5 / 12	VAL A 606 ALA A 619 LYS A 621 ILE A 885 GLY A 953	924 A1101 ( 4.8A) 924 A1101 (-3.5A) None 924 A1101 ( 4.6A) 924 A1101 (-4.6A)	0.75A	5hieA-4g34A: 3.8	5hieA-4g34A: 28.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	5 / 12	VAL A 606 ALA A 619 ILE A 885 PHE A 943 GLY A 953	924 A1101 ( 4.8A) 924 A1101 (-3.5A) 924 A1101 ( 4.6A) 924 A1101 ( 4.2A) 924 A1101 (-4.6A)	0.49A	5hieB-4g34A: 22.1	5hieB-4g34A: 28.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	5 / 12	VAL A 606 ALA A 619 LYS A 621 ILE A 885 GLY A 953	924 A1101 ( 4.8A) 924 A1101 (-3.5A) None 924 A1101 ( 4.6A) 924 A1101 (-4.6A)	0.74A	5hieB-4g34A: 22.1	5hieB-4g34A: 28.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_D_P06D801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	5 / 12	VAL A 606 ALA A 619 ILE A 885 PHE A 943 GLY A 953	924 A1101 ( 4.8A) 924 A1101 (-3.5A) 924 A1101 ( 4.6A) 924 A1101 ( 4.2A) 924 A1101 (-4.6A)	0.49A	5hieD-4g34A: 22.4	5hieD-4g34A: 28.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_D_P06D801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	5 / 12	VAL A 606 ALA A 619 LYS A 621 ILE A 885 GLY A 953	924 A1101 ( 4.8A) 924 A1101 (-3.5A) None 924 A1101 ( 4.6A) 924 A1101 (-4.6A)	0.75A	5hieD-4g34A: 22.4	5hieD-4g34A: 28.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	4 / 7	GLY A 599 GLY A 601 GLY A 604 VAL A 606	None None None 924 A1101 ( 4.8A)	0.34A	5izjB-4g34A: 21.7	5izjB-4g34A: 24.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UUN_B_ACTB310_0 (GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN)	2o7q	BIFUNCTIONAL 3-DEHYDROQUINATE DEHYDRATASE/SHIKIMAT E DEHYDROGENASE (Arabidopsis thaliana)	4 / 4	GLY A 303 PRO A 302 VAL A 299 ARG A 279	None None None DHK A9241 (-2.7A)	1.25A	5uunA-2o7qA: 0.0 5uunB-2o7qA: 0.0	5uunA-2o7qA: 20.88 5uunB-2o7qA: 20.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5VCY_A_DB8A401_1 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	6 / 12	LEU A 598 VAL A 606 ALA A 619 LYS A 621 CYH A 890 PHE A 943	924 A1101 ( 4.1A) 924 A1101 ( 4.8A) 924 A1101 (-3.5A) None 924 A1101 (-3.9A) 924 A1101 ( 4.2A)	0.36A	5vcyA-4g34A: 23.4	5vcyA-4g34A: 30.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_C_PCFC1805_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	5ju6	BETA-GLUCOSIDASE (Rasamsonia emersonii)	5 / 9	GLY A 286 LEU A 289 ILE A 322 LEU A 313 ILE A 334	MAN A 924 ( 3.7A) None None None None	0.93A	5vkqC-5ju6A: undetectable 5vkqD-5ju6A: undetectable	5vkqC-5ju6A: 19.49 5vkqD-5ju6A: 19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W5V_A_ANWA701_0 (SERINE/THREONINE-PRO TEIN KINASE TBK1)	4g34	EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (Homo sapiens)	5 / 9	LEU A 598 ALA A 619 VAL A 651 MET A 887 CYH A 890	924 A1101 ( 4.1A) 924 A1101 (-3.5A) 924 A1101 (-4.6A) 924 A1101 (-3.7A) 924 A1101 (-3.9A)	0.61A	5w5vA-4g34A: 15.1	5w5vA-4g34A: 21.25

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["2FUM_D_MIXD3539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",7,"LEU A 598;GLY A 599;GLY A 601;VAL A 606;LYS A 938;ASN A 941;ASP A 954","924 A1101 ( 4.1A);None;None;924 A1101 ( 4.8A);None;None;924 A1101 (-3.7A)","1.06A","2fumD-4g34A:23.4",null],["2HYY_A_STIA600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",4,"LEU A 598;LYS A 621;VAL A 651;ILE A 885","924 A1101 ( 4.1A);None;924 A1101 (-4.6A);924 A1101 ( 4.6A)","0.42A","2hyyA-4g34A:20.6","2fumD-4g34A:27.81"],["2HYY_B_STIB600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",4,"LEU A 598;LYS A 621;VAL A 651;ILE A 885","924 A1101 ( 4.1A);None;924 A1101 (-4.6A);924 A1101 ( 4.6A)","0.54A","2hyyB-4g34A:20.6","2hyyA-4g34A:27.27"],["2PGR_A_DCFA501_2","ADENOSINE DEAMINASE","2o7q","BIFUNCTIONAL 3-DEHYDROQUINATE DEHYDRATASE\/SHIKIMATE DEHYDROGENASE","Arabidopsis thaliana",3,"LEU A 289;LEU A 148;PHE A 291","None;None;DHK A9241 (-3.4A)","0.61A","2pgrA-2o7qA:3.7","2hyyB-4g34A:27.27"],["3CS9_A_NILA600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"LEU A 598;VAL A 606;LYS A 621;VAL A 651;ILE A 885;VAL A 952","924 A1101 ( 4.1A);924 A1101 ( 4.8A);None;924 A1101 (-4.6A);924 A1101 ( 4.6A);None","0.76A","3cs9A-4g34A:21.0","2pgrA-2o7qA:23.46"],["3CS9_B_NILB600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"LEU A 598;VAL A 606;LYS A 621;VAL A 651;ILE A 885;VAL A 952","924 A1101 ( 4.1A);924 A1101 ( 4.8A);None;924 A1101 (-4.6A);924 A1101 ( 4.6A);None","0.77A","3cs9B-4g34A:21.4","3cs9A-4g34A:27.24"],["3CS9_C_NILC600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"LEU A 598;VAL A 606;LYS A 621;VAL A 651;ILE A 885;VAL A 952","924 A1101 ( 4.1A);924 A1101 ( 4.8A);None;924 A1101 (-4.6A);924 A1101 ( 4.6A);None","0.75A","3cs9C-4g34A:20.9","3cs9B-4g34A:27.24"],["3G2O_A_SAMA500_1","PCZA361.24","2wan","PULLULANASE","Bacillus acidopullulyticus",3,"ARG A 756;GLU A 761;ASP A 815","None;GOL A1924 (-3.8A);None","0.93A","3g2oA-2wanA:undetectable","3cs9C-4g34A:27.24"],["3K5V_A_STIA2_2","TYROSINE-PROTEIN KINASE ABL1","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",4,"LEU A 598;LYS A 621;VAL A 651;ILE A 885","924 A1101 ( 4.1A);None;924 A1101 (-4.6A);924 A1101 ( 4.6A)","0.50A","3k5vA-4g34A:16.5","3g2oA-2wanA:16.34"],["3K5V_B_STIB2_2","TYROSINE-PROTEIN KINASE ABL1","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",4,"LEU A 598;LYS A 621;VAL A 651;ILE A 885","924 A1101 ( 4.1A);None;924 A1101 (-4.6A);924 A1101 ( 4.6A)","0.48A","3k5vB-4g34A:18.8","3k5vA-4g34A:26.91"],["3LXK_A_MI1A1125_1","TYROSINE-PROTEIN KINASE JAK3","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",7,"LEU A 598;GLY A 599;VAL A 606;ALA A 619;LYS A 621;VAL A 651;ASP A 954","924 A1101 ( 4.1A);None;924 A1101 ( 4.8A);924 A1101 (-3.5A);None;924 A1101 (-4.6A);924 A1101 (-3.7A)","0.67A","3lxkA-4g34A:22.3","3k5vB-4g34A:26.91"],["3MSS_D_STID1_2","TYROSINE-PROTEIN KINASE ABL1","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",4,"VAL A 606;LYS A 621;VAL A 651;ILE A 885","924 A1101 ( 4.8A);None;924 A1101 (-4.6A);924 A1101 ( 4.6A)","0.39A","3mssD-4g34A:20.3","3lxkA-4g34A:25.90"],["3OG7_A_032A1_1","AKAP9-BRAF FUSION PROTEIN","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;ALA A 619;CYH A 890;PHE A 943;PHE A 955;GLY A 956","924 A1101 ( 4.8A);924 A1101 (-3.5A);924 A1101 (-3.9A);924 A1101 ( 4.2A);924 A1101 ( 4.4A);None","0.84A","3og7A-4g34A:23.6","3mssD-4g34A:26.91"],["3OG7_A_032A1_1","AKAP9-BRAF FUSION PROTEIN","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;ALA A 619;LYS A 621;CYH A 890;PHE A 955;GLY A 956","924 A1101 ( 4.8A);924 A1101 (-3.5A);None;924 A1101 (-3.9A);924 A1101 ( 4.4A);None","0.79A","3og7A-4g34A:23.6","3og7A-4g34A:27.30"],["3OG7_A_032A1_1","AKAP9-BRAF FUSION PROTEIN","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;LYS A 621;LEU A 642;CYH A 890;PHE A 955;GLY A 956","924 A1101 ( 4.8A);None;924 A1101 (-3.9A);924 A1101 (-3.9A);924 A1101 ( 4.4A);None","0.75A","3og7A-4g34A:23.6","3og7A-4g34A:27.30"],["4DM8_B_REAB1501_1","RETINOIC ACID RECEPTOR BETA","2wan","PULLULANASE","Bacillus acidopullulyticus",5,"LEU A 762;ALA A 763;LEU A 740;PHE A 817;GLY A 778","GOL A1924 (-4.3A);None;None;None;None","1.04A","4dm8B-2wanA:undetectable","3og7A-4g34A:27.30"],["4IK6_B_LURB201_1","TRANSTHYRETIN","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",4,"MET A 887;LEU A 883;ALA A 656;LEU A 658","924 A1101 (-3.7A);None;None;None","0.82A","4ik6B-4g34A:undetectable","4dm8B-2wanA:13.15"],["4O0W_A_ADNA501_1","AURORA KINASE A","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",4,"LEU A 598;GLY A 599;VAL A 606;ALA A 619","924 A1101 ( 4.1A);None;924 A1101 ( 4.8A);924 A1101 (-3.5A)","0.26A","4o0wA-4g34A:24.3","4ik6B-4g34A:18.93"],["4RKU_A_PQNA5001_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1;PHOTOSYSTEM I REACTION CENTER SUBUNIT IX","2o7q","BIFUNCTIONAL 3-DEHYDROQUINATE DEHYDRATASE\/SHIKIMATE DEHYDROGENASE","Arabidopsis thaliana",4,"PHE A 291;SER A 300;ALA A 243;LEU A 269","DHK A9241 (-3.4A);DHK A9241 (-2.8A);DHK A9241 ( 4.6A);DHK A9241 (-3.7A)","0.96A","4rkuA-2o7qA:undetectable;4rkuJ-2o7qA:undetectable","4o0wA-4g34A:26.98"],["4RZV_B_032B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;ALA A 619;CYH A 890;PHE A 943;GLY A 953;PHE A 955","924 A1101 ( 4.8A);924 A1101 (-3.5A);924 A1101 (-3.9A);924 A1101 ( 4.2A);924 A1101 (-4.6A);924 A1101 ( 4.4A)","0.99A","4rzvB-4g34A:23.3","4rkuA-2o7qA:20.52;4rkuJ-2o7qA:7.56"],["4RZV_B_032B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;ALA A 619;CYH A 890;PHE A 943;PHE A 955;GLY A 956","924 A1101 ( 4.8A);924 A1101 (-3.5A);924 A1101 (-3.9A);924 A1101 ( 4.2A);924 A1101 ( 4.4A);None","0.80A","4rzvB-4g34A:23.3","4rzvB-4g34A:28.08"],["4RZV_B_032B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;ALA A 619;LYS A 621;CYH A 890;PHE A 955;GLY A 956","924 A1101 ( 4.8A);924 A1101 (-3.5A);None;924 A1101 (-3.9A);924 A1101 ( 4.4A);None","0.73A","4rzvB-4g34A:23.3","4rzvB-4g34A:28.08"],["4TYJ_A_0LIA801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",4,"LEU A 598;VAL A 606;LYS A 621;ILE A 650","924 A1101 ( 4.1A);924 A1101 ( 4.8A);None;None","0.49A","4tyjA-4g34A:21.6","4rzvB-4g34A:28.08"],["4XK8_A_PQNA844_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1","2o7q","BIFUNCTIONAL 3-DEHYDROQUINATE DEHYDRATASE\/SHIKIMATE DEHYDROGENASE","Arabidopsis thaliana",4,"PHE A 291;SER A 300;ALA A 243;LEU A 269","DHK A9241 (-3.4A);DHK A9241 (-2.8A);DHK A9241 ( 4.6A);DHK A9241 (-3.7A)","1.02A","4xk8A-2o7qA:undetectable","4tyjA-4g34A:24.40"],["4XV2_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;ALA A 619;CYH A 890;PHE A 943;GLY A 953;PHE A 955","924 A1101 ( 4.8A);924 A1101 (-3.5A);924 A1101 (-3.9A);924 A1101 ( 4.2A);924 A1101 (-4.6A);924 A1101 ( 4.4A)","0.78A","4xv2A-4g34A:23.6","4xk8A-2o7qA:20.59"],["4XV2_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;ALA A 619;LYS A 621;CYH A 890;GLY A 953;PHE A 955","924 A1101 ( 4.8A);924 A1101 (-3.5A);None;924 A1101 (-3.9A);924 A1101 (-4.6A);924 A1101 ( 4.4A)","0.92A","4xv2A-4g34A:23.6","4xv2A-4g34A:27.66"],["4XV2_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;CYH A 890;PHE A 943;GLY A 953;ASP A 954;PHE A 955","924 A1101 ( 4.8A);924 A1101 (-3.9A);924 A1101 ( 4.2A);924 A1101 (-4.6A);924 A1101 (-3.7A);924 A1101 ( 4.4A)","1.43A","4xv2A-4g34A:23.6","4xv2A-4g34A:27.66"],["5CSW_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;ALA A 619;CYH A 890;PHE A 943;GLY A 953;PHE A 955","924 A1101 ( 4.8A);924 A1101 (-3.5A);924 A1101 (-3.9A);924 A1101 ( 4.2A);924 A1101 (-4.6A);924 A1101 ( 4.4A)","0.77A","5cswA-4g34A:23.3","4xv2A-4g34A:27.66"],["5CSW_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",5,"VAL A 606;ALA A 619;LYS A 621;CYH A 890;PHE A 955","924 A1101 ( 4.8A);924 A1101 (-3.5A);None;924 A1101 (-3.9A);924 A1101 ( 4.4A)","0.73A","5cswA-4g34A:23.3","5cswA-4g34A:28.30"],["5CSW_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;ALA A 619;CYH A 890;PHE A 943;GLY A 953;PHE A 955","924 A1101 ( 4.8A);924 A1101 (-3.5A);924 A1101 (-3.9A);924 A1101 ( 4.2A);924 A1101 (-4.6A);924 A1101 ( 4.4A)","0.74A","5cswB-4g34A:23.3","5cswA-4g34A:28.30"],["5CSW_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;ALA A 619;LYS A 621;CYH A 890;GLY A 953;PHE A 955","924 A1101 ( 4.8A);924 A1101 (-3.5A);None;924 A1101 (-3.9A);924 A1101 (-4.6A);924 A1101 ( 4.4A)","0.92A","5cswB-4g34A:23.3","5cswB-4g34A:28.30"],["5CSW_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",5,"VAL A 606;LEU A 642;CYH A 890;PHE A 943;PHE A 955","924 A1101 ( 4.8A);924 A1101 (-3.9A);924 A1101 (-3.9A);924 A1101 ( 4.2A);924 A1101 ( 4.4A)","0.88A","5cswB-4g34A:23.3","5cswB-4g34A:28.30"],["5HES_B_032B401_1","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"VAL A 606;ALA A 619;LYS A 621;ILE A 885;PHE A 955;GLY A 956","924 A1101 ( 4.8A);924 A1101 (-3.5A);None;924 A1101 ( 4.6A);924 A1101 ( 4.4A);None","0.81A","5hesB-4g34A:22.6","5cswB-4g34A:28.30"],["5HIE_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",5,"VAL A 606;ALA A 619;ILE A 885;PHE A 943;GLY A 953","924 A1101 ( 4.8A);924 A1101 (-3.5A);924 A1101 ( 4.6A);924 A1101 ( 4.2A);924 A1101 (-4.6A)","0.49A","5hieA-4g34A:3.8","5hesB-4g34A:27.79"],["5HIE_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",5,"VAL A 606;ALA A 619;LYS A 621;ILE A 885;GLY A 953","924 A1101 ( 4.8A);924 A1101 (-3.5A);None;924 A1101 ( 4.6A);924 A1101 (-4.6A)","0.75A","5hieA-4g34A:3.8","5hieA-4g34A:28.49"],["5HIE_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",5,"VAL A 606;ALA A 619;ILE A 885;PHE A 943;GLY A 953","924 A1101 ( 4.8A);924 A1101 (-3.5A);924 A1101 ( 4.6A);924 A1101 ( 4.2A);924 A1101 (-4.6A)","0.49A","5hieB-4g34A:22.1","5hieA-4g34A:28.49"],["5HIE_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",5,"VAL A 606;ALA A 619;LYS A 621;ILE A 885;GLY A 953","924 A1101 ( 4.8A);924 A1101 (-3.5A);None;924 A1101 ( 4.6A);924 A1101 (-4.6A)","0.74A","5hieB-4g34A:22.1","5hieB-4g34A:28.49"],["5HIE_D_P06D801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",5,"VAL A 606;ALA A 619;ILE A 885;PHE A 943;GLY A 953","924 A1101 ( 4.8A);924 A1101 (-3.5A);924 A1101 ( 4.6A);924 A1101 ( 4.2A);924 A1101 (-4.6A)","0.49A","5hieD-4g34A:22.4","5hieB-4g34A:28.49"],["5HIE_D_P06D801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",5,"VAL A 606;ALA A 619;LYS A 621;ILE A 885;GLY A 953","924 A1101 ( 4.8A);924 A1101 (-3.5A);None;924 A1101 ( 4.6A);924 A1101 (-4.6A)","0.75A","5hieD-4g34A:22.4","5hieD-4g34A:28.49"],["5IZJ_F_AZ1F2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR-DAR","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",4,"GLY A 599;GLY A 601;GLY A 604;VAL A 606","None;None;None;924 A1101 ( 4.8A)","0.34A","5izjB-4g34A:21.7","5hieD-4g34A:28.49"],["5UUN_B_ACTB310_0","GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN","2o7q","BIFUNCTIONAL 3-DEHYDROQUINATE DEHYDRATASE\/SHIKIMATE DEHYDROGENASE","Arabidopsis thaliana",4,"GLY A 303;PRO A 302;VAL A 299;ARG A 279","None;None;None;DHK A9241 (-2.7A)","1.25A","5uunA-2o7qA:0.0;5uunB-2o7qA:0.0","5izjB-4g34A:24.21"],["5VCY_A_DB8A401_1","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",6,"LEU A 598;VAL A 606;ALA A 619;LYS A 621;CYH A 890;PHE A 943","924 A1101 ( 4.1A);924 A1101 ( 4.8A);924 A1101 (-3.5A);None;924 A1101 (-3.9A);924 A1101 ( 4.2A)","0.36A","5vcyA-4g34A:23.4","5uunA-2o7qA:20.88;5uunB-2o7qA:20.88"],["5VKQ_C_PCFC1805_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","5ju6","BETA-GLUCOSIDASE","Rasamsonia emersonii",5,"GLY A 286;LEU A 289;ILE A 322;LEU A 313;ILE A 334","MAN A 924 ( 3.7A);None;None;None;None","0.93A","5vkqC-5ju6A:undetectable;5vkqD-5ju6A:undetectable","5vcyA-4g34A:30.37"],["5W5V_A_ANWA701_0","SERINE\/THREONINE-PROTEIN KINASE TBK1","4g34","EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3","Homo sapiens",5,"LEU A 598;ALA A 619;VAL A 651;MET A 887;CYH A 890","924 A1101 ( 4.1A);924 A1101 (-3.5A);924 A1101 (-4.6A);924 A1101 (-3.7A);924 A1101 (-3.9A)","0.61A","5w5vA-4g34A:15.1","5vkqC-5ju6A:19.49;5vkqD-5ju6A:19.49"]]